M. Kubota et al., 2ND MALIGNANCY FOLLOWING TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA INCHILDREN, International journal of hematology, 67(4), 1998, pp. 397-401
Second malignancy is one of the serious late effects among long-term s
urvivors of acute lymphoblastic leukemia (ALL) in children. Of 83 newl
y diagnosed pediatric ALL patients at our hospital between January 198
0 and December 1995, four patients were found to have second malignanc
ies. These included MDS/AML after B-ALL, rhabdomyosarcoma after early
pre-B ALL, ependymoma after B-ALL, and astrocytoma after early pre-B A
LL. The mean duration from initial ALL, to second malignancy was 5.2 y
ears. The possible causes of second malignancy in these patients are d
iscussed in this report, along with a review of recent literature. (C)
1998 Elsevier Science Ireland Ltd. All rights reserved.